Showing results (61-70 of 798) with videos related to
Sort By:
Pageof 80
Antimicrobial Agents and Chemotherapy|April 1, 1978
Human leukocyte interferon in the treatment of varicella in children with cancer: a preliminary controlled trialA M Arvin, S Feldman, T C MeriganJournal of Immunology (Baltimore, Md. : 1950)|August 15, 1995
Characterization of HLA-A 0201-restricted cytotoxic T cell epitopes in conserved regions of the HIV type 1 gp160 proteinM Dupuis, S K Kundu, T C MeriganThe Journal of General Virology|February 1, 1980
Type I and type II interferons: differential antiviral actions in transformed cellsM F Bourgeade, C Chany, T C MeriganImmunology|April 1, 1979
In vitro production and cellular origin of murine type II interferonG Sonnenfeld, A D Mandel, T C MeriganJournal of Medical Virology|January 1, 1984
DNA of 21 clinical cytomegalovirus strains detected by hybridization to cloned DNA fragments of laboratory strain AD-169S W Chou, L Roark, T C MeriganJournal of Immunology (Baltimore, Md. : 1950)|December 1, 1979
Natural killing in estrogen-treated mice responds poorly to poly I.C despite normal stimulation of circulating interferonW E Seaman, T C Merigan, N TalalAntimicrobial Agents and Chemotherapy|August 3, 1999
Hydroxyurea enhances the activities of didanosine, 9-[2-(phosphonylmethoxy)ethyl]adenine, and 9-[2-(phosphonylmethoxy)propyl]adenine against drug-susceptible and drug-resistant human immunodeficiency virus isolatesS Palmer, R W Shafer, T C MeriganLancet (London, England)|June 27, 1981
Controlled clinical trial of intravenous acyclovir in heart-transplant patients with mucocutaneous herpes simplex infectionsS Chou, J G Gallagher, T C MeriganJournal of Acquired Immune Deficiency Syndromes|January 1, 1991
Safety and effects of interleukin-2 plus zidovudine in asymptomatic individuals infected with human immunodeficiency virusD H Schwartz, G Skowron, T C MeriganJournal of Immunology (Baltimore, Md. : 1950)|November 15, 1986
Regulation of guinea-pig immune functions by interleukin 2: critical role of natural killer activity in acute HSV-2 genital infectionA Weinberg, T Y Basham, T C MeriganPageof 80